Fresenius Kabi USA, LLC recalls Ondansetron Injection, USP, 40 mg / 20 mL, 20 mL vial, Rx Only, Fresenius Kabi USA, LLC, Lake Zurich, IL 60047, NDC 6332
Recalled June 19, 2019 · FDA recall D-1386-2019 · Fresenius Kabi USA
Hazard
Failed Impurities/Degradation Specifications. · FDA Class III
Units
11,981 units
Sold at
Nationwide within the United States
Description
Failed Impurities/Degradation Specifications.
Product
Ondansetron Injection, USP, 40 mg / 20 mL, 20 mL vial, Rx Only, Fresenius Kabi USA, LLC, Lake Zurich, IL 60047, NDC 63323-374-20
Manufacturer(s)
Fresenius Kabi USA, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →